• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ECL
Click for more information
0.00% 1.4¢

Emerging Capital Ltd

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ECL
Ann:Removal from Official List COB 27 Nov 2017 (Price Sensitive) 		24/11/17 0 863
24/11/17 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  863 
ECL
Ann:Disclosure query (Price Sensitive) 		09/11/17 0 949
09/11/17 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  949 
ECL
Ann:Response to disclosure query (Price Sensitive) 		09/11/17 0 867
09/11/17 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  867 
ECL
Ann:Continuation of Suspension (Price Sensitive) 		09/11/17 0 902
09/11/17 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  902 
ECL
Ann:Director declaration 		19/09/17 0 767
19/09/17 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  767 
ECL
Ann:Director declaration 		19/09/17 0 902
19/09/17 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  902 
ECL
Ann:Half Yearly Annexure - 30 June 2017 (Price Sensitive) 		14/09/17 0 1.4K
14/09/17 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  1.4K 
ECL
Ann:Half Year Audit Review (Price Sensitive) 		13/09/17 0 705
13/09/17 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  705 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.

Top Stories

Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear

Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
Tennant Minerals clocks high-grade gold, copper hits at Bluebird in the NT Tennant Minerals has unveiled the results of its latest drill campaign at its Bluebird project, posting "high-grade" copper and gold hits.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Drilling shows continuous Cu mineralisation at Whundo for Greentech Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.